US FDA Creating Rare Disease ‘Hub’ To Serve As Center Of Excellence

While not brandishing the name advocates have pushed for many years, the rare disease hub will play much the same role as a center of excellence in increasing collaboration between experts in the FDA drug and biologics centers.

rare disease
The CDER-CBER rare disease hub could begin emerging by the end of the year. • Source: Shutterstock

SAN DIEGO – After years of rare disease community lobbying, the US Food and Drug Administration has decided to create a rare disease center of excellence, but will not give it that title.

Key Takeaways

  • The rare disease hub will allow experts in CDER and CBER to collaborate and offer a single point of contact for sponsors.

A rare disease “hub” that would facilitate collaboration between the Center for Drug Evaluation and Research and the Center for...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from DIA

More from Conferences